Market Tracker

02/27 11:50am ET
Customize
58.67
BATS BZX Real-Time Price
As of 11:50am ET
 -0.29 / -0.49%
Today’s Change
52.49
Today|||52-Week Range
63.62
+3.31%
Year-to-Date
Bayer Q4 Net Income Down Y/Y, Provides 2015 Outlook - Analyst Blog
10:42am / Zacks.com
British Invasion: FDA May Release Genetically Modified Mosquitoes in Florida
Feb 15 / MotleyFool.com
Dow Jones (DJIA) Today: Merck (MRK) Leads The Day Higher, Intel (INTC) Lags
Feb 26 / TheStreet.com
Forget Traditional Chemotherapy! Could 3D Vaccines Eventually Cure Cancer?
Feb 15 / MotleyFool.com
Heavy News Day For Several Biotech Stocks
Feb 25 / Benzinga
Obamacare Could Soon Make These Stocks Soar
Feb 15 / MotleyFool.com
The 3 Biggest Disappointments This Earnings Season
Feb 25 / MotleyFool.com
2 Small Biotech Stocks Dreaming Big in Hepatitis C
Feb 14 / MotleyFool.com
Hospira and Celltrion launch biosimilars
Feb 24 / FT.com
1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Phar...
Feb 13 / MotleyFool.com
Merck Strikes Deal with NGM to Develop Novel Biologics - Analyst Blog
Feb 24 / Zacks.com
Investor flows reignite corporate bond issuance
Feb 06 / FT.com
Agilent-ONO Companion Diagnostics Aim - Analyst Blog
Feb 23 / Zacks.com
Merck defends children's vaccines after measles outbreak
Feb 04 / FT.com
Eli Lilly Extends Phase III Cholesterol Study by Six Months - Analyst Blog
Feb 20 / Zacks.com
Stocks: 4 things to know before the open
Feb 04 / CNNMoney.com
Dow Jones (DJIA) Today: Merck (MRK) Lower
Feb 20 / TheStreet.com
Gilead to cut price of $1,000-a-day pill
Feb 03 / FT.com
What's in Store for Endocyte (ECYT) this Earnings Season? - Analyst Blog
Feb 20 / Zacks.com
Offshore corporate cash piles at risk from Obama tax plan
Feb 02 / CNNMoney.com
$20 Billion Market: Whatbs the Best Stock to Buy?
Feb 20 / MotleyFool.com
Two military healthcare workers flown back to UK on Ebola fears
Feb 02 / FT.com
Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Feb 18 / MotleyFool.com
Big pharmaceuticals groups faces biosimilars challenge
Feb 02 / FT.com
Hospira Launches Inflectra, Remicade Biosimilar, in Europe - Analyst Blog
Feb 17 / Zacks.com
Here are the drivers of future economic growth
Feb 01 / CNNMoney.com
Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?
Feb 16 / MotleyFool.com
US profitability: the rich list
Jan 30 / FT.com
Could This Be The Biggest Advance in Hepatitis C since Gilead Sciences' Sovaldi?
Feb 16 / MotleyFool.com
Roche confident of regaining lead in cancer drugs race
Jan 28 / FT.com